Petrovax Pharm continues to implement a social program to help the country's medical institutions: in April, 39 hospitals across Russia received 7,500 packs of the original drug Longidaza®.
Advertising. NPO PETROVAKS PHARM LLC. www.longidaza.ru erir:
The drug was transferred to surgical departments for use in the postoperative period in patients to prevent adhesions in the abdominal cavity and small pelvis.
The drug was received by healthcare facilities in 26 cities and regions of Russia, including Moscow, St. Petersburg, Chelyabinsk, Samara, Makhachkala, Novosibirsk, Kazan, etc.
“We know that our drug is in demand in the postoperative rehabilitation of patients. That is why we are striving to expand not only the list of drugs transferred to clinics, but also the geography of our initiatives in order to reach as many patients as possible throughout the country with help», — underlined Nadezhda Khomyakova, Head of the Medical Department at Petrovax Pharm
«Longidase®» (bovhyaluronidase azoximer) —enzyme drug with prolonged anti-inflammatory and anti-fibrotic action. Used to treat and prevent diseases accompanied by inflammation and hyperplasia of the connective tissue — fibrosis and adhesions1 in surgery, urology, gynecology, pulmonology and other areas of medicine.
“The recovery process is as important to the successful treatment of patients after surgery as the operation itself. «Longidasa®» has an extensive evidence base, helps to reduce edema and accelerate the process of healing and tissue repair, improving the movement of interstitial fluid and preventing the appearance of new adhesions, —noted by Deputy Chief Physician for Surgery of the Samara Regional Clinical Hospital named after V .D Seredavina Pikalov Sergei Mikhailovich. —< /span> We are grateful to Petrovax for the donation of Longidaza®, thanks to which we will be able to use the original Russian drug for the treatment of even more patients.
The company has been implementing social projects for several years , including by donating original medicines to medical institutions. Thus, during the COVID-19 pandemic, clinics across Russia received more than 200,000 packs of Polyoxidonium® to protect doctors and medical personnel working in the “red zones”. In addition, in 2020, the company participated in the opening of a new covid hospital in the city hospital of Podolsk.
1. Instructions for the medical use of Longidaza®. https://petrovax.ru/upload/iblock/d6f/4ybowwzbtm6l5g4qnz5k0mbab9wzrus2/Longidaza_supp_IMP.pdf